|
Volumn 49, Issue 2, 2002, Pages 149-154
|
PEG-asparaginase (Oncaspar) 2500 u/m2 BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols
a,g b,g c,g a,g a,g d,g e,g f,g b,g c,g a,g a,g
f
MEDAC GMBH
(Germany)
|
Author keywords
Acute lymphoblastic leukaemia; PEG asparaginase; Pharmacokinetics; Reinduction; Relapse
|
Indexed keywords
ASPARAGINASE MACROGOL;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
METHOTREXATE;
PREDNISOLONE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
CANCER RECURRENCE;
CHILD;
CONTROLLED STUDY;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG MONITORING;
ENZYME ACTIVITY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
ADOLESCENT;
ANTINEOPLASTIC AGENTS;
ASPARAGINASE;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
LYMPHOMA, NON-HODGKIN;
MALE;
POLYETHYLENE GLYCOLS;
RECURRENCE;
|
EID: 0036163591
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-001-0391-5 Document Type: Article |
Times cited : (29)
|
References (22)
|